Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8315 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8315 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8295 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8287 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8239 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8239 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8192 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8187 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7228 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8122 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.8101 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.8098 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8049 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8023 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7989 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7965 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7956 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7944 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7941 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7931 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7907 |
Intermediate Similarity |
NPD37 |
Approved |
0.7901 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7874 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7874 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7874 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7861 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7853 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7845 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7833 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7803 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7765 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7765 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7733 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7705 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7697 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7688 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.768 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7657 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7598 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7594 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7586 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7574 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7572 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7557 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7529 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7526 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7524 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7514 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2532 |
Approved |
0.75 |
Intermediate Similarity |
NPD2534 |
Approved |
0.75 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2533 |
Approved |
0.75 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7472 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7471 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.745 |
Intermediate Similarity |
NPD7874 |
Approved |
0.745 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7442 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7414 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7411 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7411 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7411 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7391 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7385 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7377 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7374 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7374 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7374 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7368 |
Intermediate Similarity |
NPD3750 |
Approved |
0.736 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7358 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7356 |
Intermediate Similarity |
NPD6273 |
Approved |
0.735 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7337 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7327 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7299 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7236 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7225 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7216 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7204 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7198 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7151 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.711 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7102 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7076 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7076 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7074 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7069 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7052 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7049 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7045 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7041 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7035 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7022 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7021 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7015 |
Intermediate Similarity |
NPD3057 |
Approved |
0.7015 |
Intermediate Similarity |
NPD2491 |
Approved |
0.701 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7 |
Intermediate Similarity |
NPD1933 |
Approved |
0.6995 |
Remote Similarity |
NPD7999 |
Approved |
0.6994 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6979 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6971 |
Remote Similarity |
NPD7930 |
Approved |
0.6965 |
Remote Similarity |
NPD2494 |
Approved |
0.6965 |
Remote Similarity |
NPD2493 |
Approved |
0.6964 |
Remote Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.6963 |
Remote Similarity |
NPD8368 |
Discontinued |
0.6963 |
Remote Similarity |
NPD6764 |
Approved |
0.6963 |
Remote Similarity |
NPD6765 |
Approved |
0.6961 |
Remote Similarity |
NPD7584 |
Approved |
0.6961 |
Remote Similarity |
NPD7583 |
Approved |
0.6959 |
Remote Similarity |
NPD6651 |
Approved |
0.6946 |
Remote Similarity |
NPD9494 |
Approved |
0.6946 |
Remote Similarity |
NPD4582 |
Approved |
0.6946 |
Remote Similarity |
NPD4583 |
Approved |
0.6941 |
Remote Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD3620 |
Phase 2 |
0.6941 |
Remote Similarity |
NPD1613 |
Approved |
0.6941 |
Remote Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.694 |
Remote Similarity |
NPD5353 |
Approved |
0.6939 |
Remote Similarity |
NPD2488 |
Approved |
0.6939 |
Remote Similarity |
NPD2490 |
Approved |
0.6936 |
Remote Similarity |
NPD2438 |
Suspended |
0.6935 |
Remote Similarity |
NPD1247 |
Approved |
0.6934 |
Remote Similarity |
NPD7907 |
Approved |
0.6931 |
Remote Similarity |
NPD3533 |
Approved |
0.6931 |
Remote Similarity |
NPD2972 |
Approved |
0.6931 |
Remote Similarity |
NPD3448 |
Approved |
0.6923 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7985 |
Registered |
0.6923 |
Remote Similarity |
NPD3268 |
Approved |
0.6923 |
Remote Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6919 |
Remote Similarity |
NPD4665 |
Approved |
0.6919 |
Remote Similarity |
NPD919 |
Approved |
0.6915 |
Remote Similarity |
NPD4107 |
Approved |
0.6914 |
Remote Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD5401 |
Approved |
0.6901 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6898 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6897 |
Remote Similarity |
NPD5763 |
Approved |
0.6897 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6897 |
Remote Similarity |
NPD5762 |
Approved |
0.6897 |
Remote Similarity |
NPD4002 |
Approved |
0.6897 |
Remote Similarity |
NPD4004 |
Approved |
0.6893 |
Remote Similarity |
NPD7236 |
Approved |
0.6889 |
Remote Similarity |
NPD7239 |
Suspended |
0.6885
|
Remote Similarity |
NPD5761 |
Phase 2 |